0001278320-20-000001.txt : 20200110 0001278320-20-000001.hdr.sgml : 20200110 20200110135249 ACCESSION NUMBER: 0001278320-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200110 DATE AS OF CHANGE: 20200110 EFFECTIVENESS DATE: 20200110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioQ Pharma Inc CENTRAL INDEX KEY: 0001278320 IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-357701 FILM NUMBER: 20520472 BUSINESS ADDRESS: STREET 1: 1325 HOWARD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 4159750805 MAIL ADDRESS: STREET 1: 1325 HOWARD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: BIOQUIDDITY INC DATE OF NAME CHANGE: 20040202 D 1 primary_doc.xml X0708 D LIVE 0001278320 BioQ Pharma Inc 1325 HOWARD STREET SAN FRANCISCO CA CALIFORNIA 94103 415.975.0805 CALIFORNIA BIOQUIDDITY INC Corporation true Joshua W. Kriesel 1325 Howard Street San Francisco CA CALIFORNIA 94103 Executive Officer Director Ron Pauli 1325 Howard Street San Francisco CA CALIFORNIA 94103 Executive Officer Norvall William Jasper, Jr. 1325 Howard Street San Francisco CA CALIFORNIA 94103 Director Mark J. Ehlert 1325 Howard Street San Francisco CA CALIFORNIA 94103 Director Richard Nesbit 1325 Howard Street San Francisco CA CALIFORNIA 94103 Director Llew Keltner 1325 Howard Street San Francisco CA CALIFORNIA 94103 Director Christopher Portman 1325 Howard Street San Francisco CA CALIFORNIA 94103 Director Daniel Tasse 1325 Howard Street San Francisco CA CALIFORNIA 94103 Director Pharmaceuticals Decline to Disclose 06b false 2019-12-30 false true true true false 0 18750000 4637500 14112500 false 15 0 0 0 false BioQ Pharma Inc /s/ Joshua W. Kriesel Joshua W. Kriesel Chief Executive Officer and President 2020-01-10